Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001568249-26-000002

EVP, CHIEF LEGAL OFFICER, SEC sold 6,950 shares at $23.38 ($162,491)

  • EVP, CHIEF LEGAL OFFICER, SEC acquired 12,944 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2026-02-06 Option exercise +12,944 14,559 D
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2026-02-09 Sale −6,950 $23.38 $162,491 7,609 D
Derivatives
Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC 2026-02-06 Option exercise · Restricted Stock Units −12,944 12,945 D
Open-market sales · 6,950 sh · avg $23.38 · $162,491
Loading xslF345X05/form4-02102026_060201.xml…